Ziogas Ioannis A, Esagian Stepan M, Giannis Dimitrios, Hayat Muhammad H, Kosmidis Dimitrios, Matsuoka Lea K, Montenovo Martin I, Tsoulfas Georgios, Geller David A, Alexopoulos Sophoclis P
Department of Surgery, Division of Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN, USA; Surgery Working Group, Society of Junior Doctors, Athens, Greece.
Oncology Working Group, Society of Junior Doctors, Athens, Greece.
Am J Surg. 2021 Oct;222(4):731-738. doi: 10.1016/j.amjsurg.2021.03.052. Epub 2021 Mar 26.
We compared the outcomes of laparoscopic hepatectomy (LH) vs. open hepatectomy (OH) for intrahepatic cholangiocarcinoma (iCCA).
A systematic review of the MEDLINE, EMBASE, Scopus, and Cochrane Library databases was performed using PRISMA guidelines (end-of-search date: 08-June-2020). Individual patient data on overall survival (OS) and recurrence-free survival (RFS) were extracted. Random-effects meta-analyses, and one- and two-stage survival analyses were conducted.
Eight retrospective cohort studies comparing LH (n = 544) vs. OH (n = 2256) were identified. LH demonstrated lower overall complication (Risk ratio [RR] = 0.64, 95% confidence interval [CI]: 0.46-0.90; p = 0.01), surgical lymphadenectomy (RR = 0.74, 95% CI: 0.58-0.93; p = 0.01) and margin-positive resection (RR = 0.78, 95% CI: 0.62-0.99; p = 0.04) rates, and higher recurrence-free rate (RR = 1.24, 95% CI: 1.01-1.51; p = 0.04) vs. OH. In Cox regression, no difference was observed regarding OS (Hazard Ratio [HR] = 1.11, 95% CI: 0.65-1.91; p = 0.70) and RFS (HR = 1.19, 95% CI: 0.74-1.90; p = 0.47).
The use of LH should be considered when feasible in well-selected iCCA patients by hepatobiliary surgeons with experience in minimally-invasive surgery.
我们比较了腹腔镜肝切除术(LH)与开腹肝切除术(OH)治疗肝内胆管癌(iCCA)的疗效。
按照PRISMA指南(检索截止日期:2020年6月8日)对MEDLINE、EMBASE、Scopus和Cochrane图书馆数据库进行系统评价。提取了关于总生存期(OS)和无复发生存期(RFS)的个体患者数据。进行了随机效应荟萃分析以及单阶段和两阶段生存分析。
确定了8项比较LH(n = 544)与OH(n = 2256)的回顾性队列研究。与OH相比,LH的总体并发症发生率(风险比[RR]=0.64,95%置信区间[CI]:0.46 - 0.90;p = 0.01)、手术淋巴结清扫率(RR = 0.74,95% CI:0.58 - 0.93;p = 0.01)和切缘阳性切除率(RR = 0.78,95% CI:0.62 - 0.99;p = 0.04)更低,无复发生存率更高(RR = 1.24,95% CI:1.